Home
PLUR
PLUR News

Latest Pluri Inc. (PLUR) News on July 26, 2024

MT Newswires

8 days ago

Pluri Shares Rise After Manufacturing Accord With Kadimastem Set

Pluri’s CDMO Selected to Manufacture Kadimastem’s Novel Cell Therapy Product Candidates

GlobeNewswire

9 days ago

Pluri’s CDMO Selected to Manufacture Kadimastem’s Novel Cell Therapy Product Candidates

Pluri Announces €1 Million Proof of Concept Agreement to Enhance Global Sustainable Vegetable Supply

GlobeNewswire

19 days ago

Pluri Announces €1 Million Proof of Concept Agreement to Enhance Global Sustainable Vegetable Supply

MT Newswires

24 days ago

Pluri Appoints Liat Zalts as CFO

MT Newswires

a month ago

Sector Update: Consumer

MT Newswires

a month ago

Pluri's Ever After Foods Subsidiary Gets $10 Million Investment; Shares Rise

Pluri Subsidiary Ever After Foods Secured $10 Million Strategic Investment to Solve Cultivated Food Scalability Challenges

GlobeNewswire

a month ago

Pluri Subsidiary Ever After Foods Secured $10 Million Strategic Investment to Solve Cultivated Food Scalability Challenges

U.S. National Institutes of Health Exercises Option to Fund $1.4 Million 2nd Year Budget for Pluri’s PLX-R18 Acute Radiation Syndrome Contract

GlobeNewswire

2 months ago

U.S. National Institutes of Health Exercises Option to Fund $1.4 Million 2nd Year Budget for Pluri’s PLX-R18 Acute Radiation Syndrome Contract

Novel Medical Food Solution for the Elderly: Pluri & Wilk Collaborate to Develop Human Breast Milk-Derived Food Production on a Commercial Scale

GlobeNewswire

2 months ago

Novel Medical Food Solution for the Elderly: Pluri & Wilk Collaborate to Develop Human Breast Milk-Derived Food Production on a Commercial Scale

Pluri Third Quarter 2024 Earnings: US$1.01 loss per share (vs US$1.53 loss in 3Q 2023)

Simply Wall St.

2 months ago

Pluri Third Quarter 2024 Earnings: US$1.01 loss per share (vs US$1.53 loss in 3Q 2023)

Unleashing the Power of MAIT Cells: Pluri Launches Novel Immunotherapy Platform for Solid Tumor Cancer Treatment

GlobeNewswire

3 months ago

Unleashing the Power of MAIT Cells: Pluri Launches Novel Immunotherapy Platform for Solid Tumor Cancer Treatment

Breakthrough in Immune Cell Expansion: Pluri Granted U.S Patent for New Method

GlobeNewswire

4 months ago

Breakthrough in Immune Cell Expansion: Pluri Granted U.S Patent for New Method

Pluri’s Business Verticals Gain Traction in Global Markets; Leadership to Participate and Present in Upcoming Conferences

GlobeNewswire

4 months ago

Pluri’s Business Verticals Gain Traction in Global Markets; Leadership to Participate and Present in Upcoming Conferences

Pluri Inc. Announces 1-for-8 Reverse Share Split

GlobeNewswire

4 months ago

Pluri Inc. Announces 1-for-8 Reverse Share Split

Pluri’s Sustainable Cell-Based Coffee Addresses Critical Challenges Revealed in International Coffee Organization Market Report

GlobeNewswire

4 months ago

Pluri’s Sustainable Cell-Based Coffee Addresses Critical Challenges Revealed in International Coffee Organization Market Report

Engage with Pluri's Talent: Exciting Conference Appearances Ahead

GlobeNewswire

4 months ago

Engage with Pluri's Talent: Exciting Conference Appearances Ahead

Pluri Selected as CDMO by Remedy Cell for Cell-Derived Cell-Free Drug Manufacturing

GlobeNewswire

4 months ago

Pluri Selected as CDMO by Remedy Cell for Cell-Derived Cell-Free Drug Manufacturing

Pluri™ Receives First-Ever Patent Approval for 3D Bioreactor Technology in Plant Cell Cultivation

GlobeNewswire

5 months ago

Pluri™ Receives First-Ever Patent Approval for 3D Bioreactor Technology in Plant Cell Cultivation

Pluri Inc. Announces Appointment of Jim Roosevelt, Jr. to its Advisory Board

GlobeNewswire

5 months ago

Pluri Inc. Announces Appointment of Jim Roosevelt, Jr. to its Advisory Board

Pluri’s Innovation Across Various Industries: CEO Updates on Recent Achievements & 2024 Goals

GlobeNewswire

5 months ago

Pluri’s Innovation Across Various Industries: CEO Updates on Recent Achievements & 2024 Goals

Pluri Second Quarter 2024 Earnings: US$0.12 loss per share (vs US$0.24 loss in 2Q 2023)

Simply Wall St.

5 months ago

Pluri Second Quarter 2024 Earnings: US$0.12 loss per share (vs US$0.24 loss in 2Q 2023)

Associated Press Finance

5 months ago

Pluri: Fiscal Q2 Earnings Snapshot

Third Coast Bancshares, Inc. (NASDAQ:TCBX) Q4 2023 Earnings Call Transcript

Insider Monkey

6 months ago

Third Coast Bancshares, Inc. (NASDAQ:TCBX) Q4 2023 Earnings Call Transcript

Step into the Future: Pluri Launches Sustainable Cell-Based Coffee as Countermeasure for Global Coffee Crisis

GlobeNewswire

6 months ago

Step into the Future: Pluri Launches Sustainable Cell-Based Coffee as Countermeasure for Global Coffee Crisis

Gilead Sciences, Citi, Digital World Acquisition: Top Stocks

Yahoo Finance Video

6 months ago

Gilead Sciences, Citi, Digital World Acquisition: Top Stocks

Solid Biosciences Granted FDA Orphan Drug Designation for Duchenne Muscular Dystrophy Gene Therapy Candidate SGT-003

GlobeNewswire

6 months ago

Solid Biosciences Granted FDA Orphan Drug Designation for Duchenne Muscular Dystrophy Gene Therapy Candidate SGT-003

ReWalk Robotics Ltd. to Present at Sidoti Virtual Investor Conference on January 17

GlobeNewswire

6 months ago

ReWalk Robotics Ltd. to Present at Sidoti Virtual Investor Conference on January 17

ASHFORD HOSPITALITY TRUST ANNOUNCES PRELIMINARY FOURTH QUARTER 2023 RESULTS

PR Newswire

7 months ago

ASHFORD HOSPITALITY TRUST ANNOUNCES PRELIMINARY FOURTH QUARTER 2023 RESULTS

Pluri Launches Advanced Global Cell Therapy Contract Development and Manufacturing Organization

GlobeNewswire

7 months ago

Pluri Launches Advanced Global Cell Therapy Contract Development and Manufacturing Organization

Tiptree Inc. Announces Tax Treatment of 2023 Common Stock Distributions

Business Wire

7 months ago

Tiptree Inc. Announces Tax Treatment of 2023 Common Stock Distributions

Resources Connection, Inc. (NASDAQ:RGP) Q2 2024 Earnings Call Transcript

Insider Monkey

7 months ago

Resources Connection, Inc. (NASDAQ:RGP) Q2 2024 Earnings Call Transcript

AdTheorent Partners with Jounce Media to Verify Removal of Made for Advertising (MFA) Properties from Its Campaigns

PR Newswire

7 months ago

AdTheorent Partners with Jounce Media to Verify Removal of Made for Advertising (MFA) Properties from Its Campaigns

Pluri and Bar-Ilan University to Develop PLX Cells for the Treatment of Cocaine Addiction

GlobeNewswire

7 months ago

Pluri and Bar-Ilan University to Develop PLX Cells for the Treatment of Cocaine Addiction

Reorganization of Virtus Stone Harbor Closed-End Funds Completed

Business Wire

7 months ago

Reorganization of Virtus Stone Harbor Closed-End Funds Completed

Zentek and 1Click Heating and Cooling Sign Distribution Agreement

ACCESSWIRE

8 months ago

Zentek and 1Click Heating and Cooling Sign Distribution Agreement

Fathom Realty to raise agent fees in 2024 to boost earnings

HousingWire

8 months ago

Fathom Realty to raise agent fees in 2024 to boost earnings

Sidoti Events, LLC's Virtual December Small-Cap Conference

ACCESSWIRE

8 months ago

Sidoti Events, LLC's Virtual December Small-Cap Conference

UCloudlink Group Inc. Sponsored ADR (UCL) Beats Q3 Earnings and Revenue Estimates

Zacks

8 months ago

UCloudlink Group Inc. Sponsored ADR (UCL) Beats Q3 Earnings and Revenue Estimates

GlobeNewswire

8 months ago

UCLOUDLINK GROUP INC. Announces Unaudited Third Quarter 2023 Financial Results

Associated Press Finance

8 months ago

Pluri: Fiscal Q1 Earnings Snapshot

MISTRAS Group to Participate in Sidoti Micro Cap Virtual Conference on November 15-16, 2023

GlobeNewswire

9 months ago

MISTRAS Group to Participate in Sidoti Micro Cap Virtual Conference on November 15-16, 2023

GlobeNewswire

9 months ago

UCLOUDLINK GROUP INC. to Report Third Quarter 2023 Financial Results on November 15, 2023

The one-year earnings decline is not helping Big 5 Sporting Goods' (NASDAQ:BGFV share price, as stock falls another 25% in past week

Simply Wall St.

9 months ago

The one-year earnings decline is not helping Big 5 Sporting Goods' (NASDAQ:BGFV share price, as stock falls another 25% in past week

Share on Social Networks: